The safety and tolerability of PD-1/PDL-1 inhibitors in hematologic malignancies: A meta-analysis.

Myint, PT; Ali, F; Alrifai, T; Gong, Z; Nandar, PP; Kozma, KE

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索